OSAM
MDCO

O'Shaughnessy Asset Management’s Medicines Co MDCO Stock Holding History

O'Shaughnessy Asset Management’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-2,493
Closed -$125K – 1967
2019
Q3 		$125K Buy
+2,493
New +$99.4K ﹤0.01% 599
2013
Q3 		– Sell
-7,529
Closed -$232K – 1017
2013
Q2 		$232K Buy
+7,529
New +$252K 0.01% 502

Other funds holding MDCO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

O'Shaughnessy Asset Management's MDCO Position: Q4 2019 in Review

O'Shaughnessy Asset Management sold out of Medicines Co (MDCO) in Q4 2019, closing a stake of 2,493 shares — an estimated $125K sold.

O'Shaughnessy Asset Management first reported a position in MDCO in Q2 2013 and held it in 2 quarters. The position peaked at $232K in Q2 2013. 284 funds tracked by Wall St. Rank hold MDCO as of Q4 2019.

  • O'Shaughnessy Asset Management reported no remaining Medicines Co position as of Q4 2019 after selling out during the quarter.
  • O'Shaughnessy Asset Management sold 2,493 Medicines Co shares in Q4 2019, an estimated $125K.
  • O'Shaughnessy Asset Management first reported a position in Medicines Co in Q2 2013 and held it in 2 quarters.
  • O'Shaughnessy Asset Management's Medicines Co position peaked at $232K in Q2 2013.
  • 284 funds tracked by Wall St. Rank held Medicines Co as of Q4 2019.

Based on O'Shaughnessy Asset Management's 13F filing for Q4 2019, filed 12 Feb 2020.